HEPATOTOXICITY OF FLUOROURACIL WITH N-PHOSPHONACETYL-L-ASPARTATE

被引：0
作者：
STENRAM, U
机构：
来源：
ANNALS OF INTERNAL MEDICINE | 1992年 / 117卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：90 / 91
页数：2
相关论文
共 50 条
  • [11] Tumor, normal tissue, and plasma pharmacokinetic studies of fluorouracil biomodulation with N-phosphonacetyl-L-aspartate, folinic acid, and interferon alfa
    Harte, RJA
    Matthews, JC
    O'Reilly, SM
    Tilsley, DWO
    Osman, S
    Brown, G
    Luthra, SJ
    Brady, F
    Jones, T
    Price, PM
    JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (05) : 1580 - 1588
  • [12] CLINICAL-TRIAL OF SEQUENTIAL N-PHOSPHONACETYL-L-ASPARTATE, THYMIDINE, AND 5-FLUOROURACIL IN ADVANCED COLORECTAL-CARCINOMA
    OCONNELL, MJ
    MOERTEL, CG
    RUBIN, J
    HAHN, RG
    KVOLS, LK
    SCHUTT, AJ
    JOURNAL OF CLINICAL ONCOLOGY, 1984, 2 (10) : 1133 - 1138
  • [13] PHASE I-II TRIAL OF N-PHOSPHONACETYL-L-ASPARTATE (PALA) AND 5-FLUOROURACIL (5FU)
    ERLICHMAN, C
    DONEHOWER, RC
    KLECKER, R
    CHABNER, BA
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1981, 22 (MAR): : 366 - 366
  • [14] AN OVERVIEW OF THE CLINICAL-PHARMACOLOGY OF N-PHOSPHONACETYL-L-ASPARTATE (PALA), A NEW ANTIMETABOLITE
    ERLICHMAN, C
    RECENT RESULTS IN CANCER RESEARCH, 1980, 74 : 65 - 71
  • [15] CENTRAL NERVOUS-SYSTEM (CNS) TOXICITY OF PALA (N-PHOSPHONACETYL-L-ASPARTATE)
    WILEY, RG
    GRALLA, RJ
    CARROLL, DS
    KEMENY, N
    YOUNG, CW
    SYKES, MP
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1980, 21 (MAR): : 350 - 350
  • [16] A PHASE-I TRIAL OF COMBINED THERAPY WITH N-PHOSPHONACETYL-L-ASPARTATE (PALA) AND 5-FLUOROURACIL (5-FU)
    MESHAD, MW
    ERVIN, TJ
    JOHNSON, RK
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1980, 21 (MAR): : 341 - 341
  • [17] CYTIDINE POTENTIATES N-PHOSPHONACETYL-L-ASPARTATE ACTIVITY IN HUMAN OVARIAN-CARCINOMA CELLS
    CHAN, TCK
    HOWELL, SB
    FEDERATION PROCEEDINGS, 1985, 44 (04) : 1143 - 1143
  • [18] Design, synthesis, and evaluation of N-phosphonacetyl-L-aspartate derivatives as putative human ATCase inhibitors
    Doud, Mary
    Wolf, Caitlin
    Ponsart, Kirsten
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2017, 254
  • [19] Phase I trial of fluorouracil modulation by n-phosphonacetyl-l-aspartate and 6-methylmercaptopurine ribonucleoside (MMPR), and leucovorin in patients with advanced cancer
    Alexandre Hageboutros
    Gary R. Hudes
    Fran Greene
    Frank P. LaCreta
    James Brennan
    Peter J. O'Dwyer
    Investigational New Drugs, 1997, 15 : 139 - 145
  • [20] Phase I trial of fluorouracil modulation by N-phosphonacetyl-L-aspartate and 6-methylmercaptopurine ribonucleoside (MMPR), and leucovorin in patients with advanced cancer
    Hageboutros, A
    Hudes, GR
    Greene, F
    LaCreta, FP
    Brennan, J
    ODwyer, PJ
    INVESTIGATIONAL NEW DRUGS, 1997, 15 (02) : 139 - 145
12345